Nova Patents
ES3013301T3

Methods for determining drug efficacy using ikzf3 (aiolos)

Abstract

The invention relates to the use of the cereblon-associated proteins IKZF1 (Ikaros) and IKZF3 (Aiolos) as biomarkers for indicating the efficacy of a compound in altering the immune response in a subject and for evaluating the efficacy of a compound in treating cancer or an inflammatory disease, as well as a kit comprising the compound and a means for identifying the biomarkers. (Automatic translation with Google Translate, no legal value)

ES3013301T3, drawing sheet 1
Sheet 1 of 72

Term

6.8 yearsto projected expiry

Projected expiry 28 June 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

72 sheets

  1. Sheet 1
  2. Sheet 2
  3. Sheet 3
  4. Sheet 4
  5. Sheet 5
  6. Sheet 6
  7. Sheet 7
  8. Sheet 8
  9. Sheet 9
  10. Sheet 10
  11. Sheet 11
  12. Sheet 12
  13. Sheet 13
  14. Sheet 14
  15. Sheet 15
  16. Sheet 16
  17. Sheet 17
  18. Sheet 18
  19. Sheet 19
  20. Sheet 20
  21. Sheet 21
  22. Sheet 22
  23. Sheet 23
  24. Sheet 24
  25. Sheet 25
  26. Sheet 26
  27. Sheet 27
  28. Sheet 28
  29. Sheet 29
  30. Sheet 30
  31. Sheet 31
  32. Sheet 32
  33. Sheet 33
  34. Sheet 34
  35. Sheet 35
  36. Sheet 36
  37. Sheet 37
  38. Sheet 38
  39. Sheet 39
  40. Sheet 40
  41. Sheet 41
  42. Sheet 42
  43. Sheet 43
  44. Sheet 44
  45. Sheet 45
  46. Sheet 46
  47. Sheet 47
  48. Sheet 48
  49. Sheet 49
  50. Sheet 50
  51. Sheet 51
  52. Sheet 52
  53. Sheet 53
  54. Sheet 54
  55. Sheet 55
  56. Sheet 56
  57. Sheet 57
  58. Sheet 58
  59. Sheet 59
  60. Sheet 60
  61. Sheet 61
  62. Sheet 62
  63. Sheet 63
  64. Sheet 64
  65. Sheet 65
  66. Sheet 66
  67. Sheet 67
  68. Sheet 68
  69. Sheet 69
  70. Sheet 70
  71. Sheet 71
  72. Sheet 72